Skip to main content

Featured

Washington Signals Swift Timeline for Iran Operation

US official said that achievable objectives of Operation Epic Fury are expected to last about six weeks. The White House says it expects U.S. military objectives in Iran to be achieved within four to six weeks , emphasizing that Operation Epic Fury is progressing as planned. According to Press Secretary Karoline Leavitt, the campaign has already weakened Iran’s naval capabilities and sharply reduced missile attacks, putting the U.S. “well on its way” toward its strategic goals.  The operation, now in its second week, focuses on dismantling Iran’s ballistic missile infrastructure, degrading its navy, and limiting its pathway to nuclear weapons. Officials maintain that U.S. stockpiles and resources are sufficient to sustain the mission through its projected timeline.  As regional tensions escalate, Washington continues to frame the operation as both achievable and time‑bound, reinforcing its confidence in meeting objectives by early April.

article

Cancer-Causing Chemical Detected in Acne Treatments: Brands Under Scrutiny

 


In a recent alarming discovery, independent U.S. laboratory Valisure has detected high levels of the cancer-causing chemical benzene in certain acne treatments. Brands affected include:

  1. Clinique (Estee Lauder)
  2. Clearasil (Reckitt Benckiser-owned)
  3. Proactiv
  4. Target Corp.'s Up & Up
  5. PanOxyl
  6. Walgreens’ acne soap bar
  7. Walmart’s Equate Beauty acne cream

Benzene, a known carcinogen, was found not only in the acne products themselves but also in the air around incubated products, suggesting a potential inhalation risk. Valisure has filed a petition with the U.S. Food and Drug Administration (FDA) urging product recalls, investigations, and revised industry guidance. The situation is substantially different from previous cases where benzene impurities came from contaminated ingredients. Here, benzene originates directly from the benzoyl peroxide itself, forming at unacceptably high levels.

Consumers are advised to stay informed as regulatory responses unfold. The FDA’s reaction to Valisure’s petition remains pending. Companies implicated in this issue, including Estee Lauder, have yet to respond to media inquiries.

As we await further developments, it’s crucial to prioritize safety and informed choices when it comes to skincare products. 









Comments